Tanaka Y - Search Results

1

Structure and function analysis of urinary trypsin inhibitor (UTI): identification of binding domains and signaling property of UTI by analysis of truncated proteins.

Suzuki M, Kobayashi H, Tanaka Y, Hirashima Y, Terao T. Suzuki M, et al. Among authors: tanaka y. Biochim Biophys Acta. 2001 May 5;1547(1):26-36. doi: 10.1016/s0167-4838(01)00167-4. Biochim Biophys Acta. 2001. PMID: 11343788

2

Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways.

Kobayashi H, Suzuki M, Tanaka Y, Hirashima Y, Terao T. Kobayashi H, et al. Among authors: tanaka y. J Biol Chem. 2001 Jan 19;276(3):2015-22. doi: 10.1074/jbc.M007650200. Epub 2000 Oct 24. J Biol Chem. 2001. PMID: 11050091 Free article.

3

Characterization of binding properties of urinary trypsin inhibitor to cell-associated binding sites on human chondrosarcoma cell line HCS-2/8.

Hirashima Y, Kobayashi H, Suzuki M, Tanaka Y, Kanayama N, Fujie M, Nishida T, Takigawa M, Terao T. Hirashima Y, et al. Among authors: tanaka y. J Biol Chem. 2001 Apr 27;276(17):13650-6. doi: 10.1074/jbc.M009906200. Epub 2001 Jan 26. J Biol Chem. 2001. PMID: 11278581 Free article.

4

Identification and characterization of the cell-associated binding protein for urinary trypsin inhibitor.

Kobayashi H, Hirashima Y, Sun GW, Fujie M, Shibata K, Tamotsu S, Miura K, Sugino D, Tanaka Y, Kondo S, Terao T. Kobayashi H, et al. Among authors: tanaka y. Biochim Biophys Acta. 1998 Apr 2;1383(2):253-68. doi: 10.1016/s0167-4838(97)00215-x. Biochim Biophys Acta. 1998. PMID: 9602143

5

Serum hyaluronic acid levels during pregnancy and labor.

Kobayashi H, Sun GW, Tanaka Y, Kondo T, Terao T. Kobayashi H, et al. Among authors: tanaka y. Obstet Gynecol. 1999 Apr;93(4):480-4. doi: 10.1016/s0029-7844(98)00526-2. Obstet Gynecol. 1999. PMID: 10214818

6

Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer.

Yagi H, Miyamoto S, Tanaka Y, Sonoda K, Kobayashi H, Kishikawa T, Iwamoto R, Mekada E, Nakano H. Yagi H, et al. Among authors: tanaka y. Br J Cancer. 2005 May 9;92(9):1737-45. doi: 10.1038/sj.bjc.6602536. Br J Cancer. 2005. PMID: 15827558 Free PMC article.

7

[Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].

Hirashima Y, Shimura T, Tanaka Y, Demukai H, Kubota T, Kobayashi T, Suzuki A. Hirashima Y, et al. Among authors: tanaka y. Gan To Kagaku Ryoho. 1993 Aug;20(10):1321-6. Gan To Kagaku Ryoho. 1993. PMID: 8346930 Japanese.

8

Evoked otoacoustic emissions in sensorineural hearing impairment: its clinical implications.

Tanaka Y, Suzuki M, Inoue T. Tanaka Y, et al. Ear Hear. 1990 Apr;11(2):134-43. doi: 10.1097/00003446-199004000-00008. Ear Hear. 1990. PMID: 2340967

9

Stimulated otoacoustic emissions in children with sensorineural hearing loss.

Tanaka Y, Kodera K, Suzuki M, Suzuki J. Tanaka Y, et al. Acta Otolaryngol. 1989 May-Jun;107(5-6):383-6. doi: 10.3109/00016488909127526. Acta Otolaryngol. 1989. PMID: 2756828

10

Gamma/delta T cells provide innate immunity against renal cell carcinoma.

Kobayashi H, Tanaka Y, Yagi J, Toma H, Uchiyama T. Kobayashi H, et al. Among authors: tanaka y. Cancer Immunol Immunother. 2001 May;50(3):115-24. doi: 10.1007/s002620100173. Cancer Immunol Immunother. 2001. PMID: 11419178 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,390 results

Search Page

Filters